Xvivo Perfusion AB (OSTO:XVIVO) Price-to-Operating-Cash-Flow : 183.52 (As of Apr. 25, 2024)

View and export this data going back to 2012. Start your Free Trial

What is Xvivo Perfusion AB Price-to-Operating-Cash-Flow?

As of today (2024-04-25), Xvivo Perfusion AB's share price is kr368.50. Xvivo Perfusion AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was kr2.01. Hence, Xvivo Perfusion AB's Price-to-Operating-Cash-Flow Ratio for today is 183.52.

The historical rank and industry rank for Xvivo Perfusion AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

OSTO:XVIVO' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 45.41 Med: 149.31 Max: 3186.27
Current: 234.07

During the past 12 years, Xvivo Perfusion AB's highest Price-to-Operating-Cash-Flow Ratio was 3186.27. The lowest was 45.41. And the median was 149.31.

OSTO:XVIVO's Price-to-Operating-Cash-Flow is ranked worse than
98.4% of 438 companies
in the Medical Devices & Instruments industry
Industry Median: 20.79 vs OSTO:XVIVO: 234.07

Xvivo Perfusion AB's Cash Flow from Operations per share for the three months ended in Mar. 2024 was kr0.05. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was kr2.01.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Xvivo Perfusion AB was 63.90% per year.

During the past 12 years, Xvivo Perfusion AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 31.20% per year. The lowest was -7.10% per year. And the median was 10.50% per year.

Xvivo Perfusion AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Xvivo Perfusion AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xvivo Perfusion AB Price-to-Operating-Cash-Flow Chart

Xvivo Perfusion AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

154.41

194.06

213.13

Xvivo Perfusion AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															290.13	213.58	164.37	213.13	-

Competitive Comparison of Xvivo Perfusion AB's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Xvivo Perfusion AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xvivo Perfusion AB's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xvivo Perfusion AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Xvivo Perfusion AB's Price-to-Operating-Cash-Flow falls into.

Xvivo Perfusion AB Price-to-Operating-Cash-Flow Calculation

Xvivo Perfusion AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	368.50	/	2.008
	=	183.52

Xvivo Perfusion AB's Share Price of today is kr368.50.
Xvivo Perfusion AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr2.01.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Xvivo Perfusion AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Xvivo Perfusion AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Xvivo Perfusion AB (OSTO:XVIVO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (OSTO:XVIVO) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

XVIPF:USA 3XV:Germany

Address

Massans gata 10, P.O. Box 53015, Gothenburg, SWE, SE-400 14

Website

https://www.xvivoperfusion.com

Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Xvivo Perfusion AB (OSTO:XVIVO) Headlines

No Headlines